Clinical Trial Update: Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis [NA]

View source ↗

Summary

A clinical trial compares rifampicin versus rifabutin in patients with HIV/AIDS and pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Pulmonary Tuberculosis

Drugs mentioned

• RIFABUTIN (Rifabutin)
• Rifampicin

Snippet

Sponsor: Shanghai Public Health Clinical Center | Conditions: Tuberculosis, Pulmonary, AIDS | NA | Status: UNKNOWN